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Abstract
Objectives: In examining informed choice in cancer screening, we investigated public awareness that some screening pro-
grammes aim to prevent cancer, while others seek to detect cancer at an early stage.
Methods: A population-based survey of adults aged 50–70 in England (n¼ 1433), including data on demographic characteristics
and screening experience. Participants were asked to select the main purpose of cervical, breast, and colorectal cancer
screening (both faecal occult blood testing and flexible sigmoidoscopy).
Results: Across all four screening programmes, most people thought the main aim was to catch cancer early (71–78%). Only 18
and 14% knew that cervical screening and flexible sigmoidoscopy, respectively, are primarily preventive. Knowledge of the
preventive aspect of these two programmes was low across the board, with few demographic patterns. By contrast, 78 and
73% of the sample were aware that breast screening and the faecal occult blood test, respectively, predominantly aim to detect
cancer early. For these programmes, accurate knowledge was socially graded, lower in ethnic minority groups, and positively
associated with previous participation in the programmes.
Conclusions: Our findings suggest that although awareness of the purpose of early detection screening is high, awareness that
screening can prevent cancer is low across all demographic groups. Understanding the purpose of screening is a key aspect of
informed choice but despite current communication strategies highlighting these differences, people do not seem to have a
nuanced understanding of these differing aims. Our findings may be indicative of a broader public scepticism about the pre-
ventability of cancer.
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Introduction
As part of a broader movement to involve patients in their
health care, in recent years there has been a shift in focus
within communication about cancer screening. Previous
attempts to maximise attendance through emphasising
the beneﬁts of screening have been replaced by eﬀorts to
enable individuals tomake an informed choice, through the
provision of comprehensive information.1 Although
screening is a major public health element of cancer con-
trol, as with any public health initiative, while some indi-
viduals will gain tremendous beneﬁt through participation,
themajority of people will see no beneﬁt at all. Some people
will also be exposed to harms, including the physical and
psychological eﬀects of overdiagnosis and overtreatment,
of false positive results and subsequent investigations, and
potential delay in seeking help if a person experiences
cancer symptoms after a negative result.2
In line with the increasing emphasis on individuals
making an informed choice about cancer screening,
there has been a growing concern regarding the extent
to which people are aware of and understand these
limitations and risks. Research has shown that general
enthusiasm for screening is high, with the majority of
people endorsing the idea that cancer screening for
healthy individuals is ‘almost always a good idea’.3,4
Other research, mainly in the breast screening context,
has shown that many people are unaware of overdiagno-
sis,4–7 or ﬁnd the concept confusing,8 but once they under-
stand it, feel that it is an important factor to take into
account in screening decisions. However, even when the
concept is described, many people would still want to
know if they had a cancer that may not cause them any
harm within their lifetime3,4 or state that the information
did not change their screening intentions.6–8 Even in
Research Department of Behavioural Science and Health, UCL, London, UK
yDeceased
Corresponding author:
Jo Waller, Research Department of Behavioural Science and Health, UCL,
Gower Street, London WC1E 6BT, UK.
Email: j.waller@ucl.ac.uk
J Med Screen
0(0) 1–6
! The Author(s) 2017
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0969141317699440
journals.sagepub.com/home/msc
situations where individuals have experienced a false posi-
tive result, they remain overwhelmingly positive about
screening.3,5
Because of these ﬁndings, the majority of work on sup-
porting informed choice about screening has focused on
ways to accurately and accessibly convey information
on limitations and risks. However, for individuals to
make a truly informed decision regarding screening, it is
important that they not only understand the potential
harms and beneﬁts, but also the purpose of screening,9
including whether the screening programme in question
is predominantly designed for early detection or to pre-
vent cancer. Although there is not always a clear-cut dis-
tinction between screening tests aimed at prevention and
those aimed at early detection, the information provided
with screening invitations in England clearly identiﬁes dif-
fering aims for diﬀerent programmes. Of the three cancer
screening programmes in operation, cervical and bowel
scope screening (a once-only ﬂexible sigmoidoscopy (FS)
oﬀered as part of the bowel cancer screening programme)
are described as preventing cancer through the detection,
and subsequent removal, of pre-cancerous lesions and
polyps, respectively. Breast screening and guaiac faecal
occult blood tests (gFOBt; also oﬀered as part of the
bowel cancer screening programme) are described as
aiming to detect disease early, when treatment is more
eﬀective. Despite the NHS information leaﬂets accom-
panying invitations making the aim of each screening pro-
gramme explicit,10–13 it is not clear to what extent people
understand these diﬀerences.
This study sought to establish whether middle aged and
older adults in the general population are aware that some
cancer screening programmes aim to prevent cancer and
others aim to detect cancer early. A secondary objective
was to explore demographic correlates of accurate know-
ledge of the purpose of four types of cancer screening and
whether accurate knowledge was associated with screen-
ing experience.
Methods
Data were collected in England between March and April
2015 as part of the Attitudes and Behaviour about Cancer
UK Survey, a population-based survey of adults aged
50–70, delivered via the TNS Global Ltd omnibus.
Sample points, deﬁned using 2011 Census small area stat-
istics and the Postcode Address File, were selected using
stratiﬁed random location sampling. Within each location,
quotas were set for age, gender, working status, and pres-
ence of children in the home. The survey was conducted
using home-based computer-assisted personal interview-
ing. The measures reported here were part of a larger
module that included questions on a range of factors
related to cancer screening. This survey was exempt
from UCL ethical committee approval requirements.
Respondents were given the following statement: ‘Some
cancer screening tests are designed mainly to ﬁnd cancer
early. Others are designed to ﬁnd and treat pre-cancer
(abnormal cells that aren’t yet cancer) and prevent
cancer from developing’. They were then asked ‘For
each of these tests, could you say whether you think it’s
mainly to ﬁnd cancer early or to prevent it?’, and given the
response options: mainly to ﬁnd cancer; mainly to prevent
cancer; heard of this test but don’t know what it is (specif-
ically) designed for; never heard of this test; don’t know.
A binary variable was created for each screening pro-
gramme with the categories ‘accurate knowledge’ and
‘inaccurate knowledge’, with ‘mainly to prevent cancer’
coded as an accurate response for cervical and FS screen-
ing, and ‘mainly to detect cancer early’ coded as an accur-
ate response for breast screening and gFOBt.
Respondents were asked whether they had ever been
invited to participate in each screening programme, and if
so, whether they had attended for screening (or had com-
pleted the stool test kit in the case of gFOBt). These ques-
tions were only asked to respondents who met the inclusion
criteria for the given programme, in terms of their age and
sex (Box 1). Women in our sample aged 65–70 no longer
meet the eligibility criteria for the cervical screening pro-
gramme and were therefore not asked the invitation ques-
tion. They were therefore excluded from the ‘invitation’
analyses of cervical screening, as were men aged 65–70, to
ensure comparability within the subsample on age.
Participants who gave ‘Don’t know’ responses to the
cancer screening experience items were excluded from ana-
lysis. Participants were also excluded from programme-
speciﬁc analyses if they reported a previous diagnosis of
the type of cancer in question.
Age, gender, marital status (married or cohabiting;
single; separated, widowed, or divorced), ethnicity (white;
non-white), education (degree or higher; A-Levels, GCSEs,
ONC or BTEC; no qualiﬁcations), and social grade were
recorded for each respondent. Social grade was classiﬁed
according to the National Readership Survey system14 and
is based on occupation: A/B (managerial/ professional), C1
(supervisory), C2 (skilled manual), DE (semi-skilled or
unskilled manual/pensioners/casual workers/unemployed).
Participants were also asked whether they had ever been
diagnosed with breast, cervical, or colorectal cancer.
Data were analysed in SPSS 21.0.15 Sample character-
istics, including knowledge of the purpose of each screen-
ing programme, were described. Demographic predictors
of accurate knowledge within the total population were
examined for each screening programme using univariate
regression models, as were the associations between
screening experience (invitation and participation) and
accurate knowledge.
Box 1. Eligibility criteria for each screening programme within our
sample.
 Cervical screening: Women aged 50–64
 Breast screening: Women aged 50–70
 gFOBt: Men and women aged 60–70
 FS: Men and women aged 55–60
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Up to a total of three multivariable logistic regression
models were carried out for each screening programme.
Model 1 included all demographic variables and was car-
ried out for each of the four screening programmes. The
additional models controlled for demographic variables
and included invitation status (Model 2) or attendance
status (Model 3). Model 3 did not control for invitation
status, as only participants who had been invited were
asked about participation.
Results
In the sample of 1433 individuals aged 50–70 (mean age
60.3; SD¼ 6.29), just over half of respondents were female
(50.5%), and the majority were from white ethnic back-
grounds (93.1%; c.f. 92.4% for this age group in the
2011 census16). Most respondents were married (61.8%),
while 23.6% were separated, widowed, or divorced, and
14.6% were single. Social grades D/E contained the lar-
gest percentage of respondents (36.1%), while grades A/B,
C1, and C2 represented 20.2, 23.0, and 20.8% of respon-
dents, respectively. Almost a third of respondents had
post-school qualiﬁcations (31.5%), 40.1% had GCSEs
or A-levels, and 28.4% had no educational qualiﬁcations
(Table 1).
From our sample, of the population eligible for cervical
screening (women aged 50–64; n¼ 496), 97.9% (n¼ 477)
reported having received at least one cervical screening
invitation. Of these, 89.1% had participated at least
once. Among the eligible FS population (n¼ 273),
11.8% (n¼ 32) had received an invitation, of whom
68.8% had participated. From those men and women
aged 60–70 (n¼ 798) eligible for gFOBt screening,
85.3% (n¼ 678) reported having received at least one
stool test kit, and of these 79.3% had completed it at
least once. Among women aged 50–70 (n¼ 694) eligible
for breast screening, 98.6% (n¼ 680) reported having
received at least one invitation, and of these 90.1% had
participated at least once.
As shown in Table 2, over 70% of participants believed
that each of the four screening tests had a primary pur-
pose of detecting cancer early. The two programmes
aimed at early detection (breast and gFOBt) had the high-
est proportion of the sample accurately identifying their
purpose (77.9 and 73.2%, respectively). Only 17.6% were
able to identify prevention as the primary purpose of
cervical screening, and for FS only 13.8%. Among
respondents who answered all four knowledge questions
(n¼ 1426), only 13 individuals (0.9%) had accurate know-
ledge of the purpose of all the screening programmes,
while 99 participants (6.9%) were able to identify the pur-
pose of three of the screening programmes. The majority
(73.0%) had accurate knowledge of the purpose of two of
the screening programmes, while 12.2% (n¼ 174) of the
sample were able to correctly identify the purpose of one
of the screening programmes. A further 99 individuals
(6.9%) did not correctly identify the purpose of any of
the programmes.
For cervical screening we found no signiﬁcant associ-
ation between invitation status, participation, or any of
the demographic characteristics and accurate knowledge
of the purpose of screening, in either univariate or multi-
variate logistic regression analyses (Table 3).
We found that for FS in univariate analyses, only mari-
tal status was signiﬁcantly associated with accurate know-
ledge, with separated, widowed, or divorced participants
more likely to have accurate knowledge than the married
reference group (OR¼ 1.57, 95% CI 1.12–2.22).
Table 1. Sample characteristics.
n %
Age
50–54 351 24.5
55–59 276 19.3
60–64 354 24.7
65–70 452 31.5
Gender
Male 710 49.5
Female 723 50.5
Social Grade
A/B 289 20.2
C1 329 23.0
C2 298 20.8
D/E 517 36.1
Education
No qualifications 374 28.4
GCSE/A-Levels 527 40.1
Degree or higher 414 31.5
Ethnicity
White 1330 93.1
Non-white 99 6.9
Marital status
Married 886 61.8
Single 209 14.6
Previously married 338 23.6
Cervical screening
Eligible 496 35.0
Ever invited (of eligible) 477 97.9
Ever participated (of invited) 425 89.1
Flexible sigmoidoscopy
Eligible 273 19.2
Ever invited (of eligible) 32 11.8
Ever participated (of invited) 22 68.8
Guaiac faecal occult blood test
Eligible 798 56.2
Ever invited (of eligible) 678 85.3
Ever participated (of invited) 535 79.3
Breast screening
Eligible 694 49.4
Ever invited (of eligible) 680 98.6
Ever participated (of invited) 613 90.1
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This remained signiﬁcant after adjusting for all other
demographic predictors (OR¼ 1.62, 95% CI 1.11–2.38).
Models including screening experience revealed no associ-
ation between accurate knowledge and invitation status or
participation (Table 3).
For gFOBt, in unadjusted analyses, being older (aged
65–70; OR¼ 1.56, 95% CI 1.13–2.15), being aﬄuent
(Social Grade AB; OR¼ 1.97, 95% CI 1.39–2.80, or
Social Grade C1; OR¼ 1.38, 95% CI 1.01–1.88), having
previously received a stool kit (OR¼ 1.94, 95% CI
1.52–2.47), and having completed a stool kit (OR¼ 1.66,
95% CI 1.08–2.56) were signiﬁcantly associated with
accurate knowledge. Individuals from a non-white ethnic
Table 3. Predictors of accurate knowledge of the aim of each screening programme.
Cervical screening Flexible sigmoidoscopy gFOBt Breast screening
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Agea 0.58 0.27 0.002 0.06
50–54 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
55–59 1.18 (0.77–1.81) 0.44 1.23 (0.78–1.96) 0.38 0.79 (0.55–1.14) 0.20 0.76 (0.51–1.13) 0.17
60–64 0.95 (0.63–1.43) 0.80 0.88 (0.55–1.40) 0.59 1.27 (0.88–1.83) 0.20 0.80 (0.55–1.19) 0.27
65–70 – – 0.78 (0.50–1.24) 0.30 1.56 (1.09–2.24) 0.01 1.21 (0.82–1.78) 0.34
Gendera 0.11 0.80 0.19 0.01
Male 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
Female 1.32 (0.94–1.87) 0.11 1.04 (0.75–1.45) 0.80 1.19 (0.92–1.53) 0.19 1.48 (1.13–1.95) 0.01
Social gradea 0.43 0.99 0.11 0.08
D/E (low) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
C2 1.31 (0.79–2.19) 0.30 0.96 (0.61–1.51) 0.85 1.18 (0.83–1.67) 0.37 1.20 (0.83–1.74) 0.33
C1 1.24 (0.75–2.05) 0.40 0.94 (0.59–1.49) 0.79 1.40 (0.98–2.02) 0.07 1.71 (1.14–2.57) 0.01
A/B (high) 1.59 (0.91–2.76) 0.10 0.90 (0.53–1.53) 0.71 1.65 (1.08–2.52) 0.02 1.28 (0.82–2.00) 0.28
Educationa 0.81 0.57 0.22 0.21
No qualifications 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
GCSEs/A-Levels 1.08 (0.67–1.74) 0.75 1.23 (0.81–1.87) 0.32 0.89 (0.65–1.22) 0.45 1.24 (0.89–1.73) 0.20
Higher education 1.19 (0.69–2.05) 0.53 1.07 (0.65–1.77) 0.79 1.19 (0.80–1.77) 0.38 1.44 (0.95–2.18) 0.09
Ethnicitya 0.87 0.27 0.004 0.03
White 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
Non-white 1.06 (0.55–2.01) 0.87 1.39 (0.77–2.52) 0.27 0.51 (0.32–0.80) 0.004 0.59 (0.36–0.96) 0.03
Marital statusa 0.12 0.05 0.92 0.42
Married 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
Single 0.98 (0.58–1.67) 0.95 1.12 (0.69–1.84) 0.64 0.99 (0.68–1.44) 0.94 0.80 (0.54–1.18) 0.25
Previously married 1.51 (1.00–2.29) 0.05 1.62 (1.11–2.38) 0.01 0.94 (0.68–1.28) 0.68 0.85 (0.61–1.19) 0.35
Invitedb 0.68 0.79 <0.001 0.14
No 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
Yes 1.57 (0.19–13.13) 0.68 1.15 (0.41–3.26) 0.79 2.54 (1.62–3.99) <0.001 3.22 (0.70–14.94) 0.14
Participatedc 0.95 0.75 0.03 <0.001
No 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref) 1.00 (ref) (ref)
Yes 0.98 (0.45–2.12) 0.95 0.55 (0.01–22.90) 0.75 1.71 (1.07–2.74) 0.03 3.49 (1.85–6.58) <0.001
gFOBt: guaiac faecal occult blood test.
Values indicated in bold are significant at p< 0.05.
aMutually adjusted for all other socio-demographic characteristics.
bAdjusted for all socio-demographic characteristics, but not for participation.
cAdjusted for all socio-demographic characteristics, but not for invitation status.
Table 2. Knowledge of the purpose of each screening programme.
Cervical
(n¼ 1043)
FS
(n¼ 1431)
gFOBT
(n¼ 1430)
Breast
(n¼ 1428)
n % n % N % n %
Early
detection
1043 72.9 1019 71.2 1047 73.2 1113 77.9
Prevention 251 17.6 197 13.8 211 14.8 194 13.6
Don’t know 136 9.5 215 15.0 172 12.0 121 8.5
Percentage of respondents with accurate knowledge are presented in bold.
FS: flexible sigmoidoscopy; gFOBt: guaiac faecal occult blood test.
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background had lower odds of accurate knowledge
(OR¼ 0.45, 95% CI 0.29–0.68). The demographic pre-
dictors remained signiﬁcant in Model 1, which mutually
adjusted for all demographic variables (Table 3), with the
exception of Social Grade C1 (OR¼ 1.40, 95% CI
0.98–2.02). In Model 2, which included all demographic
variables as well as invitation status, being invited had the
strongest eﬀect on having accurate knowledge of the pur-
pose of gFOBt (OR¼ 2.54, 95% CI 1.62–3.99). In this
model, only being in social grades AB (OR¼ 1.69, 95%
CI 1.10–2.59) was associated with higher odds of accurate
knowledge. Being aged 60–64 (OR¼ 0.60, 95% CI
0.36–0.99) and from a non-white ethnic background
(OR¼ 0.55, 95% CI 0.35–0.88) were negatively associated
with accurate knowledge. With the inclusion of participa-
tion status in Model 3, no demographic characteristics
remained predictive of accurate knowledge of the purpose
of gFOBt. However, having completed a kit was predict-
ive of accurate knowledge (OR¼ 1.71, 95% CI 1.07–2.74)
in this model.
In relation to breast screening, in unadjusted analyses,
being female (OR¼ 1.34, 95% CI 1.04–1.73), being more
aﬄuent (Social Grades AB (OR¼ 1.68, 95% CI 1.18–2.40)
or C1 (OR¼ 1.94, 95% CI 1.36–2.77)), and having a
degree (OR¼ 1.60, 95% CI 1.14–2.25) were associated
with accurate knowledge of the purpose of screening,
whereas individuals from non-white ethnic backgrounds
had lower odds of having accurate knowledge compared
with those from white backgrounds (OR¼ 0.56, 95%
CI 0.36–0.86). Having been invited (OR¼ 1.37, 95% CI
1.06–1.77) and having participated (OR¼ 3.10, 95% CI
1.82–5.31) in breast screening were signiﬁcantly associated
with accurate knowledge of its purpose. Neither age nor
marital status was associated with knowledge.
Once demographic factors had been mutually adjusted
in Model 1, being female (OR¼ 1.48, 95% CI 1.13–1.95)
and from social grade C1 (OR¼ 1.71, 95% CI 1.14–2.57)
remained signiﬁcantly associated with having accurate
knowledge (Table 3). Individuals from a non-white
ethnic background remained signiﬁcantly less likely to
have accurate knowledge (OR¼ 0.59, 95% CI 0.36–
0.96). After adjusting for demographic characteristics,
invitation status was no longer signiﬁcantly associated
with accurate knowledge. Being from social grade C1
(OR¼ 1.74, 95% CI 1.16–2.61) and from a non-white
ethnic background (OR¼ 0.60, 95% CI 0.37–0.98)
remained signiﬁcantly associated with accurate know-
ledge, in the same direction as shown in Model 1. In
Model 3, individuals aged 55–59 (OR¼ 0.51, 95% CI
0.26–0.99) or 60–64 (OR¼ 0.48, 95% CI 0.25–0.90), and
those from a non-white ethnic background (OR¼ 0.36,
95% CI 0.17–0.77) were signiﬁcantly less likely to have
accurate knowledge. The diﬀerences between socioeco-
nomic grades were no longer signiﬁcant. The strongest
predictor of accurate knowledge was participation in
screening, with those who had participated at least once
being 3.49 times more likely to have accurate knowledge
(95% CI 1.85–6.58).
Discussion
Our ﬁndings strongly suggest that the general population
think of screening as a means of detecting cancer early,
with only a minority being aware of the potential of cer-
tain cancer screening programmes to prevent cancer by
identifying and treating its precursor lesions. Beliefs
were similar across screening programmes, with little evi-
dence that people distinguish between the aims of the
diﬀerent programmes, despite them being clearly stated
in NHS information leaﬂets. For the Bowel Scope (FS)
programme, which is still in the roll-out phase, this is
perhaps unsurprising, but low awareness that cervical
screening has a preventive aspect is more striking, given
that the programme has been running since 1988, with
75–80% of women participating on a regular basis.
Within our sample, previous invitation to, or participation
in cervical screening was not associated with accurate
knowledge about its purpose. Our ﬁndings suggest that
despite the development of NHS information materials
designed to facilitate informed choice, the purpose of
screening is not being successfully communicated. This
may be due to the far more dominant public discourse
surrounding the importance of early detection of cancer
and the role of screening programmes in this.
Poor awareness of the preventive purpose of cervical
screening is a ﬁnding consistent with previous studies,
which often ﬁnd women receiving pre-cancerous results
believe they have cancer.17,18 This belief contributes to the
adverse psychological consequences of an abnormal result,
which further emphasises the need to ensure that the pur-
pose of screening is understood before people take part.
It is possible that misunderstanding about the purpose
of screening may also aﬀect people’s decisions about par-
ticipation. It could be hypothesised that people with high
levels of cancer fear may avoid taking part in screen-
ing,19–21 for fear of a diagnosis, and that this could be
alleviated if the preventive aim of some of the programmes
were better understood. This may be especially important
for FS screening, as uptake of this primarily preventive
screening test is well below that of the other screening
programmes (43.1%).22
The extent to which a better understanding of the pre-
ventive aim of certain screening programmes would alle-
viate these issues is unclear. However, in the case of ductal
carcinoma in situ there is evidence that the use of terms
not containing the words cancer or carcinoma has an
impact on women’s concern and treatment prefer-
ences.23,24 This suggests that a good understanding that
cervical screening and FS aim to remove abnormalities
that are pre-cancerous may have an impact on both the
psychological consequences of abnormal results and on
behavioural intentions. However, given that the NHS
information leaﬂets already clearly state these aims, it is
unclear what changes could be made to increase engage-
ment with and understanding of the information.
Our study is not without limitations. Although we mea-
sured ‘ever’ uptake of each screening programme, and
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would therefore expect levels of participation to be higher
than routine uptake ﬁgures, it is likely that our sample was
somewhat more engaged with cancer screening than the
general population. If this were the case, it may suggest
that we overestimated public understanding of the pur-
pose of screening, at least for breast screening and
gFOBT, which both showed signiﬁcant associations
between participation and accurate knowledge. It is also
possible that, due to the nature of the Omnibus survey
design, participants will have been prompted to consider
cancer screening to a greater extent than they usually
would during daily life. We do not know the extent to
which the previous survey questions may have inﬂuenced
individual responses, and this was not assessed with other
knowledge-based questions. Likewise, population-based
sampling meant that the sample size for FS is smaller
compared with other groups, which subsequently reduced
the robustness of the statistical models for FS. Both limi-
tations may be addressed in future research, with a greater
sample size and through the development of a validated
informed choice survey. Finally, our analysis is based on
the primary purpose of screening as it is stated in the NHS
information materials and is therefore somewhat overly
simplistic. It does not take account of the fact that both
cervical and FS screening can detect cancer as well as
preventing it through the detection of precancerous
lesions or that breast and gFOBt screening could be
seen as aiming to prevent late stage disease.
Conclusions
The early detection beneﬁts of cancer screening have long
been at the forefront of campaigns to encourage screening
participation. With the recent emphasis on informed
choice, NHS leaﬂets for breast, cervix, and colorectal
screening now include information on screening harms
and on the primary purpose of each programme. Our
ﬁndings suggest that despite this, the distinction between
prevention and early detection is not clear in the minds of
the public, in particular, the potential for some of these
tests to prevent cancer. More positively, the message that
screening can detect cancer at an earlier stage appears to
be very eﬀectively communicated, leading to a high level
of awareness of this aspect of screening.
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